Human bile acid transporter ASBT (SLC10A2) forms functional non-covalent homodimers and higher order oligomers
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Date
2018Journal
Biochimica et Biophysica Acta - BiomembranesPublisher
Elsevier B.V.Type
Article
Metadata
Show full item recordAbstract
The human apical sodium-dependent bile acid transporter, hASBT/SLC10A2, plays a central role in cholesterol homeostasis via the efficient reabsorption of bile acids from the distal ileum. hASBT has been shown to self-associate in higher order complexes, but while the functional role of endogenous cysteines has been reported, their implication in the oligomerization of hASBT remains unresolved. Here, we determined the self-association architecture of hASBT by site-directed mutagenesis combined with biochemical, immunological and functional approaches. We generated a cysteine-less form of hASBT by creating point mutations at all 13 endogenous cysteines in a stepwise manner. Although Cysless hASBT had significantly reduced function correlated with lowered surface expression, it featured an extra glycosylation site that facilitated its differentiation from wt-hASBT on immunoblots. Decreased protein expression was associated with instability and subsequent proteasome-dependent degradation of Cysless hASBT protein. Chemical cross-linking of wild-type and Cysless species revealed that hASBT exists as an active dimer and/or higher order oligomer with apparently no requirement for endogenous cysteine residues. This was further corroborated by co-immunoprecipitation of differentially tagged (HA-, Flag-) wild-type and Cysless hASBT. Finally, Cysless hASBT exhibited a dominant-negative effect when co-expressed with wild-type hASBT which validated heterodimerization/oligomerization at the functional level. Combined, our data conclusively demonstrate the functional existence of hASBT dimers and higher order oligomers irrespective of cysteine-mediated covalent bonds, thereby providing greater understanding of its topological assembly at the membrane surface. Copyright 2017 Elsevier B.V.Sponsors
The research was funded by the National Institutes of Health, Institute of Diabetes, Digestive Diseases & Kidney grant # DK56631 to PWS.Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038015983&doi=10.1016%2fj.bbamem.2017.11.016&partnerID=40&md5=54092e3ea76cca1c8853d7a58c1bbd44; http://hdl.handle.net/10713/8957ae974a485f413a2113503eed53cd6c53
10.1016/j.bbamem.2017.11.016
Scopus Count
Collections
Related articles
- Tyrosine Phosphorylation Regulates Plasma Membrane Expression and Stability of the Human Bile Acid Transporter ASBT (<i>SLC</i>10<i>A</i>2).
- Authors: Chothe PP, Czuba LC, Ayewoh EN, Swaan PW
- Issue date: 2019 Aug 5
- Transmembrane domain V plays a stabilizing role in the function of human bile acid transporter SLC10A2.
- Authors: Moore RH, Chothe P, Swaan PW
- Issue date: 2013 Jul 30
- Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2.
- Authors: da Silva TC, Hussainzada N, Khantwal CM, Polli JE, Swaan PW
- Issue date: 2011 Aug 5
- Site-directed mutagenesis and use of bile acid-MTS conjugates to probe the role of cysteines in the human apical sodium-dependent bile acid transporter (SLC10A2).
- Authors: Banerjee A, Ray A, Chang C, Swaan PW
- Issue date: 2005 Jun 21
- Cytosolic half of transmembrane domain IV of the human bile acid transporter hASBT (SLC10A2) forms part of the substrate translocation pathway.
- Authors: Khantwal CM, Swaan PW
- Issue date: 2008 Mar 25